SCHEMBL25002831

SCHEMBL25002831

CN/C=C(\C=N)c1cc(Nc2ncc(Br)c(Nc3ccc4nccnc4c3P(C)C)n2)c(OC)cc1N1CCC(N2CCC(OC)CC2)CC1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25002766 0.94 EGFR (0.54) EGFR
SCHEMBL25002419 0.93 EGFR (0.47) EGFR
SCHEMBL25001878 0.91 EGFR (0.53) EGFR
SCHEMBL25001823 0.90 EGFR (0.47) EGFR
SCHEMBL25001663 0.89 EGFR (0.47) EGFR
SCHEMBL25002771 0.89 EGFR (0.48) EGFR
SCHEMBL25002699 0.88 EGFR (0.45) EGFR
SCHEMBL25001797 0.87 EGFR (0.48) EGFR
SCHEMBL25002436 0.86 EGFR (0.44) EGFR
SCHEMBL25002042 0.85 EGFR (0.44) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129996-A1 NOVEL AMINOPYRIMIDINE EGFR INHIBITOR QILU PHARMACEUTICAL CO., LTD. (CN) 2023-02-08 — — EP disclosed
Send feedback